MD-76R - 0019-1317-11 - (Diatrizoate meglumine and Diatrizoate sodium)

Alphabetical Index


Drug Information of MD-76R

Product NDC: 0019-1317
Proprietary Name: MD-76R
Non Proprietary Name: Diatrizoate meglumine and Diatrizoate sodium
Active Ingredient(s): 660; 100    mg/mL; mg/mL & nbsp;   Diatrizoate meglumine and Diatrizoate sodium
Administration Route(s): INTRAVENOUS
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of MD-76R

Product NDC: 0019-1317
Labeler Name: Mallinckrodt Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019292
Marketing Category: NDA
Start Marketing Date: 19890929

Package Information of MD-76R

Package NDC: 0019-1317-11
Package Description: 12 BOTTLE, GLASS in 1 BOX (0019-1317-11) > 150 mL in 1 BOTTLE, GLASS

NDC Information of MD-76R

NDC Code 0019-1317-11
Proprietary Name MD-76R
Package Description 12 BOTTLE, GLASS in 1 BOX (0019-1317-11) > 150 mL in 1 BOTTLE, GLASS
Product NDC 0019-1317
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Diatrizoate meglumine and Diatrizoate sodium
Dosage Form Name SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19890929
Marketing Category Name NDA
Labeler Name Mallinckrodt Inc.
Substance Name DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Strength Number 660; 100
Strength Unit mg/mL; mg/mL
Pharmaceutical Classes Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]

Complete Information of MD-76R


General Information